Company intelligence / Profile preview
Rowpar Pharmaceuticals
Bridgewater, New Jersey, United Statesrowpar.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Rowpar’s CloSYS line of stabilized chlorine dioxide-based rinses and toothpastes are commercially available OTC products. Clinical studies have shown efficacy in reducing plaque, gingival inflammation, bleeding on probing, peri‑implant mucositis, and investigationally reducing SARS-CoV‑2 viral load. The company received FDA attention regarding unapproved drug claims related to COVID‑19.
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Small molecule (stabilized chlorine dioxide)Over-the-counter drug products (mouthwash, toothpaste)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Rowpar Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rowpar Pharmaceuticals.